Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.
Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.
复制标题
DOI:
10.1111/j.1460-9568.2011.07660.x
复制
发表时间:
2011-05
期刊:
影响因子:
--
通讯作者:
Sidhu A
中科院分区:
文献类型:
--
作者:
Haggerty T;Credle J;Rodriguez O;Wills J;Oaks AW;Masliah E;Sidhu A
Although clinically distinct diseases, tauopathies and synucleinopathies share common genesis and mechanisms, leading to overlapping degenerative changes within neurons. In human postmortem striatum of Parkinson’s disease [PD] and PD with dementia, we have recently described elevated levels of tauopathy, indexed as increased hyperphosphorylated Tau [p-Tau]. Here we assessed tauopathy in striatum of a transgenic animal model of PD, overexpressing human α-synuclein under the PDGF promoter. At 11 months of age, large and progressive increases in p-Tau in transgenic mice, hyperphosphorylated at sites reminiscent of Alzheimer’s disease, were noted, along with elevated levels of α-synuclein and p-GSK-3β, a major kinase involved in hyperphosphorylation of Tau. Differential Triton X-100 extraction of striata showed the presence of aggregated α-Syn in the Tg mice, along with p-Tau and p-GSK-3β, which was also confirmed through immunohistochemistry. After p-Tau formation, both Tau and MAP1 dissociated from the cytoskeleton, consistent with diminished ability of these cytoskeleton-binding proteins to bind microtubules. Increases in free tubulin and actin were also noted, indicative of cytoskeleton remodeling and destabilization. In vivo magnetic resonance imaging of the transgenic animals showed a reduction in brain volume of transgenic mice indicating substantial atrophy. From immunohistochemical studies, α-synuclein, p-Tau and p-GSK-3β were found to be overexpressed and co-localized in large inclusion bodies, reminiscent of Lewy bodies. The elevated state of tauopathy seen in these PDGF-α-synuclein mice provides further confirmation that Parkinson’s may be a tauopathic disease.
登录
查看更多内容
影响因子:
5.3
作者:
Frasier, M;Walzer, M;Wolozin, B
通讯作者:
Wolozin, B
影响因子:
4.7
作者:
Jeannotte, Alexis M.;Sidhu, Anita
通讯作者:
Sidhu, Anita
影响因子:
2.9
作者:
Joyce, JN;Ryoo, HL;Adler, CH
通讯作者:
Adler, CH
影响因子:
3.3
作者:
Muntane, G.;Dalfo, E.;Ferrer, I.
通讯作者:
Ferrer, I.
影响因子:
14.5
作者:
Ling, Helen;O'Sullivan, Sean S.;Lees, Andrew J.
通讯作者:
Lees, Andrew J.